Abstract:OBJECTIVE:To examine the association of preoperative carcinoembryonic antigen (CEA) level with the efficacy of neoadjuvant radiochemotherapy and postoperative metastasis and relapse in patients with rectal cancer.METHODS:Between January 2011 and January 2014, 325 patients with local advanced rectal cancer underwent preoperative radiochemotherapy and radical operation in Department of Colorectal Cancer Surgery, Beijing University Cancer Hospital, including 194 males and 131 females. According to preoperative MRI, all the patients suffered from clinical T3-4 tumors or positive lymph nodes. Their Zubrod-ECOG-WHO score was 0-1. These patients received preoperative intensity modulated radiotherapy which consisted of 50.6 Gy in 22 fractions (IMRT GTV 50.6 Gy/CTV 41.8 Gy/22 f) with capecitabine(825 mg/m2, twice per day) as radiosensitizer. According to the preoperative serum CEA level, patients were divided into high group (125 cases) and normal group (200 cases). In high group, serum CEA level decreased into normal range in 60 patients (high-normal group) after radiochemotherapy, while it was still in high level in other 65 patients (high-high group). The differences in sensitivity to radiochemotherapy and 3-year disease free survival (DFS) of these patients were both evaluated.RESULTS:In high group and normal group, the complete response rates were 18.4% (23/125) and 17.5% (35/200) (χ2=0.319, P=0.660); the percentages of tumor regression grade(TRG) 0-1 patients were 68.0%(85/125) and 67.5%(135/200)(χ2=0.009, P=0.925); the T downstage rates were 63.2%(79/125) and 70.0%(140/200)(χ2=1.266, P=0.274), respectively, whose differences were all not significant. The 3-year DFS rate in high group was 62.4%, which was significantly lower than 93.5% in normal group (χ2=53.147, P=0.000). There were 65 patients in high-high group, accounting for 52% (65/125) of high group. Among these 65 patients, 44(67.7%) presented recurrence and metastasis within 3 years and the 3-year DFS was 32.3%, which was much lower than 95.0% of 60 patients in high-normal group(χ2=182.085, P=0.000).CONCLUSIONS:Preoperative serum CEA level may not be used to predict tumor response of rectal cancer patients who receive preoperative radiochemotherapy. However, the prognosis of patients with high CEA level is worse. Recurrence and metastasis are more likely to occur in patients with high CEA level after radiochemotherapy.

Clinical Significance of Peripheral Blood PGE2 Level in Patients with Colorectal Carcinoma

The Dynamic Changes of PGE2 and Sil-2R in Patients with Colorectal Carcinoma Pre-and Post-Operation and the Clinical Significance

The dynamic changes and their correlation of PGE2 , IL-2 and CD4+/CD8+ in patients with colorectal carcinoma pre- and post-operation

Significance of Elevated Serum PGI and PG II Levels in Patients with Gastric Cancer after Total Gastrectomy

Changes in levels of portal venous blood PGI2 and TXA2 in patients with colorectal carcinoma

P-0041 the Prognostic Significance of Perineural Invasion in Patients of Gastric Cancer

Role Of Blood Tumor Markers In Predicting Metastasis And Local Recurrence After Curative Resection Of Colon Cancer

Dissemination Profile of Perioperative Tumor Cells in Peripheral Blood of Colorectal Cancer Patients Detected by Multiple Marker Genes

COLORECTAL Polymeric Immunoglobulin Receptor Expression is Correlated with Hepatic Metastasis and Poor Prognosis in Colon Carcinoma Patients with Hepatic Metastasis.

Prognostic Significance of Preoperative Serum Carcinoembryonic Antigen Varies with Lymph Node Metastasis Status in Colorectal Cancer

Predictive value of preoperative routine examination for the prognosis of patients with pT2N0M0 or pT3N0M0 colorectal cancer

Correlation between Metabolite of Prostaglandin E2 and the incidence of colorectal adenomas

Postoperative Carcinoembryonic Antigen (CEA) Levels Predict Outcomes after Resection of Colorectal Cancer in Patients with Normal Preoperative CEA Levels.

Study on VEGF-C and Sil-2R in Blood Associated with Laparoscopic Radical Resection of Rectal Cancer

Alteration of pre- and postoperative circulating DNA level in colorectal cancer patients and its significance

Clinical significance of peripheral blood-derived inflammation markers in advanced gastric cancer after radical resection

Detection of VEGF in Patients with Colorectal Cancer and Its Clinical Significance

Perioperative changes of inflammation-based biomarker for predicting the prognosis in colorectal cancer patients: a retrospective analysis

[Predictive Value of Serum Carcinoembryonic Antigen Level in Efficacy and Prognosis for Patients with Rectal Cancer Following Preoperative Radiochemotherapy].

[Detection and Clinical Significance of Plasma Vascular Endothelial Growth Factor Level in Gastrointestinal Stromal Tumor Patients].

Prognostic Significance of Pretreatment Serum Carcinoembryonic Antigen Levels in Gastric Cancer with Pathological Lymph Node-Negative: A Large Sample Single-Center Retrospective Study.